We are live on ! Find out more
BA

Bridgewater Advisors Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+22.9%
3 Year Est. Return
+61.02%
5 Year Est. Return
+71.76%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$20M
Cap. Flow
+$14.9M
Cap. Flow %
12.51%
Top 10 Hldgs %
40.12%
Holding
106
New
13
Increased
20
Reduced
31
Closed
8
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.5 quarters
Top 20 Avg Time Held
1.8 quarters

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.93M
2
AGN
Allergan Inc
AGN
+$1.73M
3
BG icon
Bunge Global
BG
+$1.32M
4
SEB icon
Seaboard Corp
SEB
+$1.08M
5
C icon
Citigroup
C
+$275K

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.96%
2 Consumer Staples 12.66%
3 Energy 10.34%
4 Industrials 8.2%
5 Healthcare 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DD icon
51
DuPont de Nemours
DD
$17.6B
$528K 0.44%
4,050
– –
2013 Q4
2 quarters
CAG icon
52
Conagra Brands
CAG
$6.44B
$521K 0.44%
22,572
– –
2013 Q4
2 quarters
VO icon
53
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$511K 0.43%
17,216
– –
2013 Q4
2 quarters
PL icon
54
DELISTED
PROTECTIVE LIFE CORP
PL
$489K 0.41%
7,055
-1,947
-22% -$111K
2013 Q4
2 quarters
GWX icon
55
State Street SPDR S&P International Small Cap ETF
GWX
$920M
$483K 0.4%
+13,700
New +$467K
2014 Q2
0 quarters
GL icon
56
Globe Life
GL
$12.6B
$454K 0.38%
8,322
– –
2013 Q4
2 quarters
T icon
57
AT&T
T
$152B
$440K 0.37%
16,461
+178
+1% +$4.77K
2013 Q4
2 quarters
PM icon
58
Philip Morris
PM
$314B
$412K 0.34%
4,882
+101
+2% +$8.7K
2013 Q4
2 quarters
WFC icon
59
Wells Fargo
WFC
$253B
$387K 0.32%
7,366
-2,368
-24% -$119K
2014 Q1
1 quarter
RTX icon
60
RTX Corp
RTX
$251B
$384K 0.32%
5,285
– –
2013 Q4
2 quarters
KMB icon
61
Kimberly-Clark
KMB
$32.5B
$375K 0.31%
3,519
– –
2013 Q4
2 quarters
TD icon
62
Toronto Dominion Bank
TD
$188B
$367K 0.31%
7,145
-214
-3% -$10.4K
2013 Q4
2 quarters
CM icon
63
Canadian Imperial Bank of Commerce
CM
$99.1B
$343K 0.29%
7,695
+98
+1% +$4.26K
2013 Q4
2 quarters
ORCL icon
64
Oracle
ORCL
$429B
$333K 0.28%
8,212
– –
2013 Q4
2 quarters
VZ icon
65
Verizon
VZ
$173B
$331K 0.28%
6,773
-586
-8% -$28.4K
2013 Q4
2 quarters
TPZ icon
66
Tortoise Electrification Infrastructure ETF
TPZ
$122M
$329K 0.28%
11,560
– –
2013 Q4
2 quarters
NVS icon
67
Novartis
NVS
$273B
$294K 0.25%
3,625
+43
+1% +$3.38K
2013 Q4
2 quarters
DD icon
68
DELISTED
Du Pont De Nemours E I
DD
$289K 0.24%
4,649
– –
2013 Q4
2 quarters
KMR
69
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$281K 0.24%
3,678
-503
-12% -$35.7K
2014 Q1
1 quarter
LINE icon
70
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$276K 0.23%
8,545
-155
-2% -$4.55K
2014 Q1
1 quarter
VBR icon
71
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.6B
$274K 0.23%
2,600
– –
2013 Q4
2 quarters
DEO icon
72
Diageo
DEO
$48.2B
$271K 0.23%
2,131
+114
+6% +$14.4K
2013 Q4
2 quarters
VBK icon
73
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.4B
$271K 0.23%
2,125
– –
2013 Q4
2 quarters
NVO icon
74
Novo Nordisk
NVO
$171B
$268K 0.22%
11,618
+16
+0.1% +$353
2013 Q4
2 quarters
VB icon
75
Vanguard Morningstar Small-Cap ETF
VB
$78.1B
$268K 0.22%
2,292
– –
2013 Q4
2 quarters

Similar funds

Bridgewater Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Bridgewater Advisors held 106 positions worth $119M, up 20% from $99.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Bridgewater Advisors deployed $14.9M of net new capital in Q2 2014, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 32% a quarter earlier, followed by Consumer Staples and Energy.

On the sell side, the largest reduction was Pfizer, an estimated $1.93M trimmed.

  • Bridgewater Advisors's largest Q2 2014 buy was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
  • Bridgewater Advisors added most to Colgate-Palmolive in Q2 2014, an estimated $4.38M increase.
  • Bridgewater Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.93M.
  • Bridgewater Advisors fully exited Allergan Inc in Q2 2014, selling an estimated $1.73M.
  • Bridgewater Advisors's ten largest holdings make up 40% of its $119M portfolio in Q2 2014.
  • Bridgewater Advisors opened 13 new positions and closed 8 in Q2 2014.
  • Bridgewater Advisors's portfolio value rose 20% quarter-over-quarter to $119M.

Based on Bridgewater Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.